PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31488185-0	2019	Minor ginsenoside F1 improves memory in APP/PS1 mice.	Ginsenosides	6-17	amyloid beta (A4) precursor protein	Mus musculus	40-47	
35054451-2	2022	Although the effects of ginsenosides on amyloid beta (Abeta) aggregation in the brain are known, the role of ginsenoside F1 remains unclear.	Ginsenosides	24-36	amyloid beta (A4) precursor protein	Mus musculus	54-59	
35054451-4	2022	Treatment with 2.5 muM ginsenoside F1 reduced Abeta-induced cytotoxicity by decreasing Abeta aggregation in mouse neuroblastoma neuro-2a (N2a) and human neuroblastoma SH-SY5Y neuronal cell lines.	Ginsenosides	23-34	amyloid beta (A4) precursor protein	Mus musculus	46-51	
35054451-7	2022	Immunostaining results indicate that ginsenoside F1 reduces Abeta plaques in the hippocampus of APPswe/PSEN1dE9 (APP/PS1) double-transgenic Alzheimer"s disease (AD) mice.	Ginsenosides	37-48	amyloid beta (A4) precursor protein	Mus musculus	60-65	
31488185-5	2019	Here, we report that a minor ginsenoside F1 improves memory function in APPswe/PSEN1dE9 (APP/PS1) double-transgenic Alzheimer"s disease (AD) model mice.	Ginsenosides	29-40	amyloid beta (A4) precursor protein	Mus musculus	89-96	
30535776-7	2019	Ginsenoside CK was found to enhance memory function, normalize neuronal morphology, decrease neuronal apoptosis, increase superoxide dismutase and glutathione peroxidase levels, reduce malondialdehyde levels, inhibit Abeta expression, and activate the Nrf2/Keap1 signaling pathway in scopolamine-exposed animals.	Ginsenosides	0-11	amyloid beta (A4) precursor protein	Mus musculus	217-222	
27840193-0	2016	Ginsenoside Re reduces Abeta production by activating PPARgamma to inhibit BACE1 in N2a/APP695 cells.	Ginsenosides	0-11	amyloid beta (A4) precursor protein	Mus musculus	23-28	
27840193-4	2016	Ginsenoside Re has been reported to decrease Abeta in Alzheimer"s disease animal models, but the mechanism has not been fully elucidated.	Ginsenosides	0-11	amyloid beta (A4) precursor protein	Mus musculus	45-50	
27840193-6	2016	Our results showed that ginsenoside Re decreased the Abeta levels in N2a/APP695 cells.	Ginsenosides	24-35	amyloid beta (A4) precursor protein	Mus musculus	53-58	
27840193-13	2016	Therefore, ginsenoside Re may be a promising agent for the modulation of Abeta-related pathology in AD.	Ginsenosides	11-22	amyloid beta (A4) precursor protein	Mus musculus	73-78